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GENERAL INTRODUCTION 
SIP24 is a glycoprotein secreted from quiescent mouse Balb/c 3T3 cells (1-3). It can be 
induced by serum, basic fibroblast growth factor (bFGF), phorbol myristate acetate, 
prostaglandin F-2a and dexamethasone (1-3). It is a superinducible protein because it can be 
fiirther induced if the cells are pretreated with the protein synthesis inhibitor, cycloheximide (1-
3). SIP24 has been purified and partially sequenced in our laboratory (3). 
24P3 cDNA was originally cloned from a subtractive library made from SV-40 infected 
primary mouse kidney cells (4). It was found that 24P3 mRNA was induced 12-17 fold after SV-
40 infection, and the induction required the synthesis of wild-type SV-40 large T antigen. 
Polyoma virus induced 24P3 to a lesser extent under the same conditions. Recently, I have 
identified SIP24 as the product of mouse 24P3 mRNA (5). Therefore, in this thesis the protein 
is referred to as SIP24/24P3. 
SIP24/24P3 has also been identified as a new member of the lipocalin femily (6,7). Lipocalins 
are a group of binding proteins for small hydrophobic molecules (6-11). Examples of lipocalins 
include serum retinol-binding protein, a-1 acid glycoprotein and prostaglandin D synthase. 
Lipocalins are believed to be transporters for small hydrophobic ligands. There is increasing 
evidence to suggest that many lipocalins bind to specific cell surface receptors (8). It has been 
suggested that many lipocalins may be involved in mediating cell homeostasis (6,8). Some 
lipocalins, including ot-1 acid glycoprotein and retinol-binding protein, are also acute phase 
proteins (6,12, 13). 
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The acute phase response (APR) is a complex host response to various inflammatory or 
stressful sdmuli such as infection, wounding, or elevated levels of stressfiil and tissue-damaging 
agents (12-14). The APR is the earliest and most immediate response among a series of 
reactions imtiated by the host in an effort to prevent ongoing tissue damage, isolate and destroy 
the infective organism and return the organism to normal function. 
Acute phase proteins (APPs) or reactants are a group of proteins whose plasma 
concentrations change rapidly during the APR (12-14). Well known APPs include C-reactive 
protein, a-1 acid glycoprotein, serum amyloid A protein, and retinol-binding protein. Liver is 
the m^or site of APP synthesis (14,15), but many APPs are also synthesized extrahepatically (15, 
16). The APPs have been demonstrated both in vitro and in vivo to be regulated by various 
factors including cytokines, glucocorticoids and growth factors (12, 14, 17-26). 
Even though the fiinctions of most APPs are still unknown, the APPs are generally believed 
to play an anti-inflammatory role in vivo. For example, otj-macroglobulin, a positive APP, is a 
protdnase inhibitor with wide spectrum of specificity (27, 28). During APR, ocj-macroglobulin 
is as a general inhibitor for the proteinases that are released from damaged cells and thus helps 
to prevent tissue damage. Another example is the negative APP transferrin, which transports 
iron in the bloodstream. Downregulation of transferrin during the APR may contribute to 
reducing the av^lability of iron for bacterial growth (12). 
NGAL (neutrophil gelatinase associated lipocalin) is the human homolog of SIP24/24P3 (29-
32). NGAL was first purified in 1992 and the partial sequence showed homology with 
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SIP24/24P3 and the rat ocj microglobulin related protein (29). It was named NGAL because the 
protein was found to be covalently linked with neutrophil gelatinase (29, 30), a neutral 
metalloprotdnase which is able to degrade extracellular matrix proteins and may be involved in 
a number of processes including inflammation and tumor invasion (33-37). However, the 
majorities of both NGAL and gelatinase are separated from each other and located in different 
secretory granules in neutrophils (32). Recent evidence suggests that NGAL may be directly 
involved in inflammation. NGAL was shown to be able to bind to fMLP (N-formylmethionyl-
leucyl-phenylalanine) (38, 39), a chemotactic factor for neutrophils (40-42) and macrophages 
(43). 
The rat homolog of SIP24/24P3, ocj-microglobulin related protein, was fortuitously cloned 
by Chan et al. (44). The result of sequence comparison showed that ocj-microglobulin related 
protein is 86% and 76% identical with SIP24/24P3 with respect to their mRNA and protein 
sequences respectively (31). Northern blot revealed that the mRNA of otj-microglobulin related 
protein is 1 kb in length and an increased expression of this mRNA can be found in liver when 
injured. It was determined that the mRNA of otj-microglobulin related protein increases 10-fold 
in the liver of male rats 18 hours after hepatectomy. 
Inflammation is a localized protective response following infection, trauma, or other tissue-
damaging stimuli (39-43,45-48). Inflammation involves a series of pro-inflammatory agents that 
initiate and amplify the inflammatory process and an array of anti-inflammatory factors that 
protect the host from unnecessary inflammation as well as terminate the inflammatory process. 
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The host inflammatory response is both local and systemic (12, 17). The APR is part of the 
systemic response, whereas noitrophil infihration into the site of inflammation is a characteristic 
of the local inflammatory response. 
Neutrophils or polymorphonuclear leukocytes (PMNs) are specialized phagocytic cells (49). 
Neutrophils are generated in the bone marrow and distributed between marginated and 
circulating pools. Neutrophils are involved in host defenses against all classes of infectious 
agents as well as in the pathology of various inflammatory conditions (47, 49). Neutrophils are 
the first cells to arrive at a local tissue site once inflammation occurs (50). The mobilization of 
neutrophils to the site of inflammation (chemotaxis) is initiated by a number of chemotactic 
fectors or chemoattractants (40-42, 51, 52). At the site of inflammation, neutrophils fulfill their 
function by phagocytosis and by releasing cytotoxic cellular contents which thus amplifies the 
inflammation process (37, 45-49). 
Neutrophils possess oxidative and nonoxidative mechanisms that enable them to eliminate 
both invading organisms and damaged host cells (47,48). The oxidative mechanism involves 
generation of reactive oxygen metabolites including hydrogen peroxide (H2O2) and the hydroxyl 
radical (HO-)- Nonoxidative mechanisms involve the production of various proteolytic and 
saccharolytic enzymes including collagenase Jind lysozyme. Microbes are eliminated by the 
process of phago<^osis and the subsequent oxidative and nonoxidative degradation. Neutrophil 
release of cytotoxic cellular contents creates a microbicidal environment which is also harmful 
to the host tissues. 
The chemotactic factors for neutrophils include N-formyl peptides (e.g. fMLP), interleukin 
5 
8 (IL-8), platelete activating fector (PAF), leukotriene B4 (LTB4) and complement fragment 5a 
(C5a) (51). Among them, N-formyl peptides and their receptor have received most study (53-
59). N-formyl-peptides are produced at the inflamed site by pre-existing neutrophils and 
macrophages from sources of bacterial and host mitochondrial proteins (40-42). Neutrophils 
respond to N-formyl peptides in a concentration dependent manner (51). At low concentrations 
(10''-10'*M), neutrophils take on a polarized shape and migrate to the high end of the peptide 
gradient. At high concentrations (>10"'M), neutrophils no longer move along the gradient but 
discharge their cellular contents. 
Activation of neutrophils by N-formyl peptides is mediated by a cell surface receptor (55, 56). 
The N-formyl peptide receptor has been cloned in human (55). The receptor is associated with 
a GTP-binding protein which is sensitive to pertussis toxin (56). Upon activation, the receptor 
is subsequently down-regulated, and repeated exposure to agonist results in desensitization of 
the signal transduction pathway (55). In neutrophils, expression of the N-formyl peptide receptor 
is increased in septic and posttraumatic patients (57). Priming factors including tumor necrosis 
factor (TNF) and colony-stimulating factor (CSF) stimulate neutrophils to a primed state which 
is more responsive towards subsequent stimulation by N-formyl peptides (51). 
Relative to its initiation, the control and termination of the inflaoMnation process are less well 
understood. It is known that fMLP is also a chemotactic factor for macrophages (43). It has 
been suggested that macrophages may be involved in the elimination of aging or apoptotic 
neutrophils at the site of inflammation and therefore control the inflammation process (60, 61). 
Coincidently, SIP24/24P3 is also a major protein secreted from mouse PU5.1.8 macrophage cells 
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stimulated by lipopolysaccharide (62). 
In the present study, I proved that SIP24 and 24P3 are the same protein. Then I tested the 
hypothesis that SIP24/24P3 is a new APP. This was accomplished by examination of 
SIP24/24P3 mRNA expression in various organs during turpentine induced APR. At the same 
time, the change of SIP24/24P3 protein level in bloodstream during APR was also examined. 
The results indicate that SIP24/24P3 is indeed dramatically induced during the APR, and that 
liver is the major site of SIP24/24P3 synthesis. The hepatic pattern of SIP24/24P3 regulation 
by the major APR mediators (TNF-a and IL-6) was determined in BNL (Balb/c normal liver) 
cells. 
Because SIP24/24P3 was also found to be expressed at a significant level in the uterus during 
the APR as well as in midgestation, I performed a time course study of SIP24/24P3 expression 
during pregnancy. The expression of SIP24/24P3 mRNA was examined in the uterus and the 
liver, and the distribution of SIP24/24P3 protein was examined in the bloodstream and the 
amniotic fluid. SIP24/24P3 expression increased to a high level in the uterus around birth. The 
possible function of SIP24/24P3 and its involvement in the host inflammatory response are 
discussed. 
Thesis Organization 
This thesis includes a general introduction, two journal articles and a general summary 
section. One of the journal articles has been published in The Journal of Biological Chemistiy, 
the other one is to be submitted for publication to The Journal of Molecular Reproduction. The 
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Pliers have been presented in the form required by the specific journals. All the references cited 
in the general introduction and general summary are included in the reference section following 
the general summary section. 
8 
roENTIFICATION OF A NEW ACUTE PHASE PROTEIN 
A paper published in the Journal, The Journal of Biological Chemistry 
Vol. 270, No. 38, Issue of September 22, pp. 22565-22570, 1995 
Quansheng Liu and Marit Nilsen-Hamilton 
Department of Biochemistry and Biophysics, Iowa State University, Ames, Iowa 50011 
ABSTRACT 
We have previously reported mouse SIP24 protein as a secreted inducible protein produced 
by quiescent Balb/c 3T3 cells. SIP24 can be produced in response to many factors, including 
serum, basic fibroblast factor (bFGF), prostaglandin F2a, phorbol ester, and dexamethasone. 
Here we present evidence to show that SIP24 is the product of mouse 24P3 mRNA. 
The 24P3 cDNA was originally cloned fi-om an SV-40-transformed quiescent mouse primary 
kidney cell culture, and it has been classified as a new member of the lipocalin protein family. 
We show that the SIP24/24P3 protein and mRNA increase dramatically in mouse serum and liver 
during the acute phase response induced by turpentine injection. Injection of mice with 
dexamethasone caused a modest increase of SIP24/24P3 mRNA in the liver. Tissue distribution 
studies revealed that SIP24/24P3 is mainly expressed in liver during the acute phase response. 
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SIP24^4P3 was also detected in the brain and the uterus. In mouse BNL (Balb/c normal liver) 
cells, the production of SIP24/24P3 is stimulated by TNF-a, which is a major regulator of the 
expression of other acute phase proteins. From its pattern of regulation we conclude that 
SIP24/24P3 is a new type-1 acute phase protein. 
INTRODUCTION 
The acute phase response (APR) is a complex reaction to various inflammatory or stressful 
stimuli such as surgery, wounding, bacterial or virus infection, or elevated levels of stressful and 
tissue damaging agents. During this mammalian stress response, the plasma levels of a group 
of proteins change rapidly. These proteins are called the acute phase proteins (APPs; 1-3). 
Those proteins whose plasma levels increase are called positive APPs; examples include C-
reactive protein, ttj-acid glycoprotein (AGP), oj-macroglobulin, and haptoglobin. The plasma 
levels of negative APPs decrease in response to inflammation or other invasive stress; examples 
include retinol-binding protein and albumin. The APPs are mainly synthesized in the liver and 
are secreted into the bloodstream (4). The precise functions of many APPs are still largely 
unknown. It is generally believed that the APPs play an anti-inflammatory role to prevent 
ongoing tissue damage and to return the organism to normal function. The known functions of 
APPs can be classified into three categories, including the maintenance of homeostasis, the 
transport of a variety of factors, and defense against infection (3). 
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The regulation of hepatic APP production is mediated by several classes of factors (2,3,5): 
First, the interleukin-l-type cytokines, which include interleukin la, interleukin Ip, tumor 
necrosis fector a, and tumor necrosis factor p, induce type-1 APPs such as human C-reactive 
protan and rat haptoglobin. The interleukin type-1-like cytokines also decrease the expression 
of type-2 APPs. Second, the interleukin-6-type cytokines, which include interleukin 6 (IL-6), 
interleukin 11, loikaemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor primarily 
induce type-2 APPs such as rat ocj-macroglobulin. Third, glucocorticoids are believed to play 
a permissive role during the APR because by themselves they cause small increases in the 
production of most APPs but strongly enhance the effect of cytokines on most APPs. Fourth, 
growth fktors such as FGF, insulin, transforming growth fector p, and hepatocyte growth factor 
regulate APPs in a way similar to glucocorticoids. Experimentally, the APR can be induced by 
injection of animals with inflammatory agents such as turpentine (1,6). 
We have reported previously the induction, characterization, purification, and partial peptide 
sequencing of a superinducible protein, SIP24, produced by quiescent Balb/c 3T3 mouse 
fibroblast cells (7-9). SIP24 is a 24 kDa secreted glycoprotein induced by serum, basic 
fibroblast growth factor (bFGF), prostaglandin F2a (PGF2a), phorbol ester, and dexamethasone. 
It is superinducible because it can be further induced in a synergistic manner with growth factors 
if the cells are pretreated with the protein synthesis inhibitor, cycloheximide. We have identified 
SIP24 as the protein product of the mouse 24P3 mRNA, whose cDNA was originally cloned 
fi-om SV-40 infected mouse kidney primary cell cultures (10). The 24P3 protein is also a major 
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secretory protein of cultured mouse PUS. 1.8 macrophage cells which have been stimulated by 
lipopolysaccharide (11). 
Based on the amino acid sequence deduced from its cDNA, Flower et al. (12) identified 24P3 
as a new member of the lipocalin protein family. Proteins closely related in sequence to 24P3 
are rat protein and human neutrophil gelatinase associated lipocalin 
(12,13). The lipocalin family is mainly composed of extracellular ligand binding proteins with 
high spedficity for small hydrophobic molecules. Examples of lipocalin family members include 
ttj-acid glycoprotein (AGP), otj-microglobulin, plasma retinol binding protein, and j3-
lactoglobulin. Some lipocalin proteins, including AGP, ocj-niacroglobulin and retinol-binding 
protein, are also APPs, and they can be regulated by glucocorticoids in vitro and in vivo (2,3). 
Here we present evidence to show that SIP24/24P3 is highly induced during the APR in vivo 
and it is mainly expressed in liver during the APR. SIP24/24P3 is also expressed in the brain and 
the uterus. Moreover, the expression of SIP24/24P3 can be related in cultured cells by TNF-a 
which is a major mediator of the APR. Our results also show that SIP24/24P3 is a type-1 APP. 
MATERIALS AND METHODS 
Ma/enoZs-Dexamethasone and cycloheximide were purchased from Sigma Chemical Company 
(St. Louis, MO). For studies with cultured cells, the dexamethasone was dissolved in ethanol 
as a 1,000-fold concentrated stock. The dexamethasone stocks used for injection into animals 
were prepared from the water-soluble form of dexamethasone encapsulated in 2-hydroxy-propyl-
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P-cyclodextrin (Sigma). 2-hydroxy-propyl-p-cyclodextrin dissolved in water at the same 
concentration as for in the dexamethasone-containing solutions was used for the control (vehicle) 
injections. The turpentine used for inducing the APR in mice was purchased from E. E. 
Zimmermann (Pittsburgh, PA). Polyclonal anti-SIP24 serxim was raised in a rabbit in our 
laboratory (9). Two preparations of rabbit polyclonal anti-24P3 sera (376 & 377) were gifts 
from Dr. Lydie Meheus (Innogenetics Institute, Ghent, Belgium). A 5' segment of 24P3 cDNA 
was a gift from Dr. Suzanne Hraba-Renevey (Embryologie Moleculaire et Morphogenese 
Institute, Geneva, Switzerland). The mouse ai-acid glycoprotein (mAGP) isoform 3X cDNA 
from mouse strain M. caroli was a gift from Dr. Heinz Baumann (Roswell Park Cancer Institute, 
Buffalo, NY). Cloned rat 18S rRNA in plasmid pDF8 was a gift from Drs. Richard Torczynski 
and Harris Busch (Wadl^ Institutes of Molecular Biology, Dallas, TX; 14). Recombinant mouse 
IL-6 (1.0X10' U/p-g) and TNF-a (4.2X10® U/jig) were purchased from Boehringer Mannheim 
Corp. (Indianapolis, IN). Trans^'S-label was from ICN (Costa Mesa, CA). Nitrocellulose 
membranes were purchased from Micron Separations Inc. (Westboro, MA), and Zeta-Probe 
nylon membranes were from BIO-RAD Laboratories (Hercules, CA). Dulbecco-Vogt's modified 
Eagle's (DME) medium, calf serum, penicillin, and streptomycin were from GIBCO/BRL 
(Gaithersburg, MD). 
Cell cw/ft/re-Stock cultures of mouse Balb/c 3T3 and BNL cells were grown in Dulbecco-Vogt's 
modified Eagle's (DME) medium with both 10% calf serum and 10 U/ml each of penicillin and 
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streptomycin. The cultures were maintained at 37°C in a humidified atmosphere of 10% CO, 
in air. 
Cell culture cmd preparation of medium containing S7/'2-#-BaIb/c 3T3 cells or BNL cells were 
plated on plastic dishes in DME containing 10% calf serum and 10 U/ml penicillin-streptomycin. 
After the cells had reached confiuency, the medium was changed to 2% calf serum. Two to three 
days later the cells were treated with cycloheximide, dexamethasone, IL-6, or TNF-a in serum 
firee DME medium as described for each experiment. The media were then collected and 
centrifuged to remove cell debris, the supematants were lyophilized, and the pellets were 
redissolved in distilled HjO and stored at -20 °C until use. 
Western Blot y4«a(v5/s-Samples of concentrated conditioned culture media and diluted serum 
samples were resolved by SDS-PAGE (9,15), and the proteins were transferred to nitrocellulose 
membranes (16). The transferred proteins were detected by immunostaining using either the 
Stratagene Picoblue alkaline phosphatase kit to produce a blue stain or horse radish peroxidase 
conjugated secondary antibody (Organon Teknika Corp., West Chester, PA) and ECL Western 
blotting detection reagents (Amersham corp., Arlinton Heights, EL) to produce a luminescent 
stain. 
Induction of the Acute Phase Response in M/ce-Turpentine or 0.9% sterile saline (5 ml/kg body 
wt) were injected intramuscularly into five-week-old to six-month-old male and female CF-1 
mice. Dexamethasone or the vehicle alone (5 mg/kg body wt) were injected intraperitoneally. 
Twelve hours after injection, blood samples fi-om each mouse were taken by tail-bleeding. 
Twenty-four hours after injection, the mice were sacrificed by cervical dislocation. Blood 
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samples were taken immediately by heart puncture and incubated at 37°C for 1 hour. A spatula 
was used to detach the clots from the walls of the tube every 15 min. The samples were then 
spun in a microcentrifuge for 5 min at room temperature. The supematants (sera) were 
collected for later Western blot analysis. From the same animal, the liver and other organs were 
quickly collected, frozen in liquid nitrogen, and stored at -70"C prior to RNA extraction. 
UNA analysis-For extraction of total RNA, organs were homogenized in 4 M guanidine 
isothiocyanate (GIT) buffer and centrifiiged through CsCl (17). Northern blot analysis was 
carried out by separation of IS p.g of total RNA on 0.9% agarose gel containing formaldehyde. 
The contents of the gel were transferred to nylon membranes and hybridized to ^^-labeled 24P3 
5' r^on cDNA probe (440 bp), mAGP cDNA probe (700 bp), and rat 18S rRNA cDNA probe 
(750 bp EcoRI/PstI fragment). The membranes were stripped between hybridization with the 
different probes. The RNA band was visualized by autoradiography. The results were 
quantitated by using phosphorimager (Molecular Dynamics, Sunnyvale, CA). Tests of the 
quantitative nature of the data obtained from the phosphorimager showed that the amount of 
radioactivity reported by the instrument was linear with respect to that determined by scintillation 
spectrometry over a range of 0 to 2 x 10® cpm per band. 
Peptide Sequence Analysis-SIFIA was purified and sequenced as described prevdously (9). 
Metabolic Labeling of SIP24/24P3-'Si^ cells were grown to quiescence. Interleukin-6 or 
TNF-a were added at the final concentrations described for each experiment and the cells were 
incubated for 24 hours. The medium was then removed and the cells were rinsed twice vwth Tris 
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buffered salts. The cells were then metabolically labeled for 4 hours by incubation with 100 
p.Ci/ml of Trans^'S-label in DME (with 10% of the normal methionine concentration), 0.2% calf 
serum and the same additions as present during the previous 24-hour incubation. Detmls of this 
procedure have been described (7-9,15). The samples of medium were resolved by SDS-PAGE, 
the gels were impregnated with 2,5-diphenyloxazole and exposed to film. The relative amounts 
of SIP24/24P3 produced under each test condition were quantitated by densitometric analysis 
of the resulting fluorograms. The resuhs fi'om densitometry which were proportional to the 
relative amount of radioactive label associated with each protein band were normalized to the 
TCA-precipitable cpm in the post-nuclear supernatant of the cell population corresponding to 
the sample of conditioned medium. In this way, the rate of incorporation into each secreted 
protein was normalized to the overall rate of protein synthesis. 
RESULTS 
SIP24 shares extensive identity with the deduced amino acid sequence of 24P3-'We have 
previously reported the purification and partial sequencing of SIP24 (9). In those studies, four 
peptides fi'om clostripain-digested SIP24 were chosen to sequence and to compare with 
GenBank and EMBL databases. No identical sequence was found. The longest peptide (peptide 
B) showed 94% identity with mouse cyclophilin, and other peptides showed some identity with 
cyclophilin. From these results, SIP24 was thought to be a cyclophilin-like protein. 
The sequences of seven peptides obtained from a clostripain digestion of the purified SIP24 
protein were compared with the sequences found in an updated SwissProt database. All peptide 
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sequences except peptide B were found to share identity with the deduced amino acid sequence 
of 24P3 cDNA (Fig. 1). The six SIP24 peptides that are identical to 24P3 cover 25% of the 
complete 24P3 sequence and are spread over the entire 24P3 coding region. The 24P3 cDNA 
was cloned by Hraba-Renevey et al. (10) from quiescent mouse kidney primary cell cultures 
infected by SV-40. 24P3 mRNA can also be induced by serum in 3T3 fibroblast cells as can the 
SIP24 protdn (7,10). These findings suggested that SIP24 is the product of the 24P3 mRNA, 
and that peptide B containing the cyclophilin-like sequence came from a contaminating protein 
in the SIP24 preparation. As judged by the area under the peptide B peak after reverse-phase 
HPLC chromatography, the molar ratio of the cyclophilin-like peptide to the other peptides in 
the clostripain digests was less than 0.4 (the sequencing of this peptide did not go to 
completion). Although such a molar ratio could have arisen because a larger proportion of 
peptide B was lost during the procedure, it is also consistent with peptide B having been derived 
from contaminating protein. 
Anti-SIP24 and anti-24P3 immune sera recognize the same protein -To test the hypothesis that 
Sff24 and 24P3 are the same protein, we performed Western blot analyses with anti-SIP24 and 
two preparations of anti-24P3 antisera raised against the 24P3 protein expressed in E.coli. The 
concentrated control and SIP24-contairang media were blotted with either anti-SIP24 or anti-
24P3 sera. The antibodies raised against 24P3 detected the same protein band in the SIP24-
enriched medium as did anti-SIP24 serum (Fig. 2). To rule out the possibility that anti-SIP24 
and anti-24P3 sera recognized two diflferent proteins of similar apparent size, a mixture of anti-
SIP24 and anti-24P3 sera was also tested, and the result showed a single stained band (Fig. 2). 
Figure 1. Comparison between the SIP24 and 24P3 deduced amino acid sequences. The lower horizontal line represents the 24P3 
sequence. All numbers except the first and the last indicate the amino acid position on the deduced 24P3 protein sequence at which 
the sequences of the peptides shown for SIP24 begin. Position 1 is the first amino acid in the 24P3 sequence that includes a putative 
signal sequence. Identities of sequence between the SIP24 and 24P3 are indicated by a line on the 24P3 map without interruptions 
of the amino acid letter code. The single location in which the sequence of one of the S1P24 peptides did not match the 24P3 
sequence is indicated with a letter internipting the line representing 24P3. The mismatch was found in peptide E in which a glycine 
was found in the SIP24 peptide sequence in the position of a lysine in the 24P3 sequence. The sequences of peptides A, C, and D 
have been reported previously (9). Peptide E, F, G are newly identified and sequenced peptides from a clostripain digest of S1P24. 
The symbol ? in the sequence of peptide G indicates that the amino acid in this position was not detected as a recognizable peak. 
^ ^ _L_TFVPSSR__^_ ^ 
OLRZ4 SDQFR ONAVQGKTE RYWIR AGQFTLGN KTSENKQYF7ITLYGR 
24P3 rn i—i n rn 1—i 
I 45 49 59 67 101 119 149 164 200 
Figure 2. Recognition of SIP24 by antisera raised against 24P3 by Western blot analysis. Quiescent Balb/c 3T3 cells were 
incubated witii or without 1 ^g/nll cyclohexiniide and 400 ng/nil dexamcthasone (DFiX/CHX) in seruni-frce DME medium for 18 
hours. The media were concentrated and resolved by SDS-PAGE, and the Western blots were stained with pre-immune serum (PI), 
anti-SIP24 (a-SIP24), or two preparations of anti-24P3 sera (376, 377) either alone or as a 1:1 mixture. The Western blot was 
visualized by using the Stratagene Picoblue alkaline phosphatase kit. Arrows on the left indicate the positions of the molecular 
weight markers expressed in thousands, from top to bottom: bovine serum albumin (67,000), ovalbumin (45,000), carbonic 
anhydrase (30,000), myoglobin (18,000), and cytochrome c (12,500). 
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Therefore, the results of Western blot analysis support the prediction from the analysis of SIP24-
derived peptide sequences that SIP24 protein and 24P3 mRNA are derived from the same or 
from two very closely related genes. 
24P3 mENA and SIP24 protein both increase dramatically during the acute phase response-To 
test the hypothesis that SIP24/24P3 is an acute phase protein, we induced the APR in male and 
female mice by injection with turpentine. Twenty-four hours after injection, total RNA was 
extracted from mouse liver and analyzed by Northern blot. The 24P3 cDNA probe recognized 
an uniform band corresponding to an mRNA of about 1.0 kb, which was in perfect agreement 
with the previously reported size of 24P3 mRNA (10). The 24P3 mRNA level was very low 
or undetectable in the livers of uninjected (data not shown) or of saline-injected mice, whereas 
the livers of both male and female mice injected with turpentine had increased levels of this 
mRNA (Fig. 3 A). The relative amounts of 24P3 mRNA were determined after normalizing the 
values for band densities of 24P3 mRNA to the band densities of 18S rRNA on the same blots. 
The average ratio of normalized 24P3 mRNA in the turpentine-injected mice over normalized 
24P3 mRNA in the control mice was 416±107 (N=12). The membranes were also hybridized 
with the mAGP cDNA probe. The ratio of normalized mAGP mRNA in the livers of turpentine-
injected vs. saline-injected animals was calculated to be 12±4 (N=6). This result matches well 
the 10 to 20 fold increase in mAGP mRNA after turpentine injection which was reported by 
Prowse and Baumann. (18). 
To determine the effect of turpentine injection on the level of SIP24/24P3 in the bloodstream, 
sera from saline- and turpentine-injected mice were collected 12 and 24 hours after 
Figure 3A. Northern blot of saline- and turpentine-injeaed mouse liver total RNA. Male and 
female mice were injected with 0.9% sterile saline (Saline) or turpentine (Turpentine). 
Twenty-four hours after injection, total RNAs were extracted from the livers and resolved 
by agarose gel electrophoresis. The resolved RNAs were transferred to nylon membranes 
and hybridized sequentially with ^-labeled 24P3, mAGP, and rat 18S rRNA cDNA probes. 
The same experiment was performed twice, and a total of 12 mice (6 male and 6 female) were 
treated under each condition. Numbers on the right show the positions of the 18S and 28 S 
rRNA markers and the estimated molecular weight of the 24P3 mRNA. 
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Figure 3B. Western blot analysis of sera from saline- and turpentine-injected mice. The same male and female mice were used 
as for (A). Serum samples were prepared 12 and 24 hours after injection of saline or turpentine. Samples (30 pi) of 2.5% sera were 
resolved by SDS-PAGE and blotted against pre-immune serum (PI) and anli-SIP24 serum (a-SIP24) as described in 
Materials and Methods. A sample of SIP24-enriched cell culture medium as used in Fig.2 was included as positive control (C). 
Numbers on the left indicate molecular weight markers in thousands. 
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injection, and SIP24 was detected by Western blot analysis. As in the results for the Northern 
blots of 24P3 mRNA, SIP24 protein was undetectable in sera from saline-injected mice. But, 
SIP24 was detected in sera from turpentine-injected mice. Sera collected at both 12 and 24 h 
after injection of turpentine had elevated levels of SIP24 (Fig. 3B). There was no observable 
difference between the sexes in the extent to which SIP24 was elevated. Thus, as for 24P3 
mRNA in liver, turpentine treatment elevated the SIP24 protein level in the bloodstream. 
Dexamethasone induces a modest increase in 24P3 mRNA in //ver-Because dexamethasone 
induces SIP24/24P3 in cultured Balb/c 3T3 cells and regulates the APR in vivo, we also 
exanmed the 24P3 mRNA and SIP24 protein levels in dexamethasone-injected mouse livers and 
sera by Northern and Western blot analysis respectively. Twenty-four hours after injection of 
the vehicle, 24P3 mRNA was veiy low or undetectable in the injected control mouse livers. By 
comparison, 24 h after the injection of dexamethasone there was a modest but obvious elevation 
in the liver 24P3 mRNA level (Fig. 4). The increase in 24P3 mRNA in the livers of 
dexamethasone-injected mice compared with control mice was 8±3 fold (N=12). Like 
turpentine, dexamethasone had similar effect in male and female mice. Northern blot analysis of 
mAGP mRNA showed the expected marginal increase (1.25±0.18 fold over control; N=6) of 
mAGP mRNA after dexamethasone treatment. Unlike its rat counterpart, mouse AGP is only 
induced about 1.5-fold after glucocorticoid treatment (18). The SIP24 protein could not be 
detected in the sera from either vehicle- or dexamethasone-injected mice by Western blot analysis 
(data not shown). 
Figure 4. Northern blot analysis of total RNA isolated from the livers of vehicle- and 
dexamethasone-injected mice. Male and female mice were injected with 2-hydroxy-propyl-(3-
cyclodextrin (C) or dexamethasone in 2-hydroxy-propyl-3-<yclodextrin (DEX). Twent>'-four 
hours after injection, total liver RNAs were extracted and resolved by agarose gel 
electrophoresis. The RNAs were then transferred to a nylon membrane and hybridized 
sequentially with '^-labeled 24P3, mAGP, and rat 18S rRNA probes. The same experiment 
was performed twice, and a total of 12 mice (6 male and 6 female) were used for each 
condition. 
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SIP24/24P3 is meanly expressed in liver-Ths tissue distribution of 24P3 mRNA was determined 
by Northern blot analysis. Twenty-four hours after saline or turpentine injection, total RNAs 
from liver, heart, kidney, lung, brain, skeletal muscle, and uterus were extracted and analyzed. 
As shown in Fig. S, 24P3 mRNA was almost undetectable in all tissues from saline-injected mice. 
Of the tissues from turpentine-treated mice, the liver showed an obvious elevation in 24P3 
mRNA The 24P3 mRNA was not detected in samples from the heart, kidney, lung, and muscle 
of turpentine-injected mice. However, 24P3 mRNA was detected in the brain and uterus, 
although its level of expression in these tissues was much lower than in liver. When 24P3 
mRNA levels from turpentine-injected mice were compared in these tissues after being 
normalized to the levels of 18S RNA, the relative ratios were 1.00±0.80, 0.01±0.00 and 
0.19±0.00 (N=3) in liver, brain, and uterus, respectively. Thus, it seems that SIP24/24P3 is 
mainly expressed in liver during the APR. 
SIP24/24P3 expression duringpregnancy-lhQ reproductive system has been reported to express 
a number of APPs during pregnancy, including rat ceruloplasmin, transferrin, retinol-binding 
protein, oj-macroglobulin, and others (4). The expression of SIP24/24P3 during mouse 
pregnancy was examined by Northern blot analysis. SIP24/24P3 message was found in the liver 
and uterus, but not in the placenta or fetus of day 11 pregnant mice (Fig.6). The proportion of 
SIP24/24P3 mRNA was about the same in the uteri and livers of five midpregnant (day 11) mice. 
Interleukin-6 and tumor necrosis factor-a induce SIP24/24P3-VJe used BNL cells, a normal liver 
cell line, to test the cellular responses of SIP24 production to treatment with either of two major 
Figure 5. Tissue distribution of 24P3 inRNA in saline- and turpcnline-injected animals. Twenty-four hours after injection of 
saline (-) or turpentine (<). tola' RNAs were extracted from difterent tissues and resolved by agarose gel electrophoresis. Three 
diflerent mice (one male and two females) were used as sources of the tissues. The RNAs were transferred to nylon membranes 
and hybridized with labeled 24P3 and rat 18S rRNA probes. The figure shows representative results from one of each of the 
tissues. 
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Figure 6. 24P3 mRNA expression during pregnancy. Total RNAs from the maternal liver, 
uterus, placentae, and fetuses of day 11 mid-gestation female mice were extracted and 
hybridized with labeled 24P3 and rat 18S rRNA probes. 
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APR regulating fectors. Quiescent BNL cells were treated with IL-6, TNF-a, and combinations 
of both for 24 hours, and then metabolically labeled for 4 hours. The media containing ^*S-
methionine-labeled proteins were analyzed for relative rates of SIP24 synthesis as described in 
Materials and Methods. The results are shown in Fig.7A and Table 1. Interleukin-6 had little 
or no effect on SIP24 production by BNL cells, whereas TNF-a induced SIP24. The 
combination of 100 U/ml IL-6 and 1 ng/ml TNF-a treatment resuhed in about 1.4-fold increase 
of SIP24 as obtained with TNF-a treatment alone. Thus, IL-6 and TNF-a acted synergistically 
to increase SIP24 production by BNL cells. Western blot analysis was performedin parallel to 
confirm the identification of the SIP24/24P3 protein produced by BNL cells. As shown in 
Fig.7B, anti-SIP24 serum detected SIP24/24P3 in medium from TNF-a-treated BNL cells, but 
not from IL-6-treated cells. 
Figure 7A. Regulation by IL-6 and TNF-a of SIP24 synthesis and secretion. Quiescent 
BNL cells were incubated for 24 h with IL-6, TNF-a, and the combination of both factors. 
The cuhure media containing radiolabeled secreted proteins were resolved by SDS-PAGE 
and analyzed by fluorography as described in Materials and Methods. The concentrations 
used of IL-6 (10-1000 U/ml) and of TNF-a (0.1 to 10 ng/ml) are shown for each lane . 
Numbers on the left show the positions of the proteins used as molecular weight markers 
with their molecular weights expressed in thousands. 
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Figure 7B. Western blot analysis of secreted S1P24. Quiescent BNL cells were incubated for 24 h with lL-6 and TNF-a in 
serum-free DME medium. The culture media were collected, centrifuged, lyophilized, and rcdissolved in distilled H2O to 1/10 of 
the original volume. The concentrated media were resolved by SDS-PAGE, and the Western blots were stained with pre-immune 
serum (PI) or anti-SlP24 (a-SlP24). The same SIP24-enriched medium as used in Fig.2 was included as positive control 
(DEX/CHX). Numbers on the left indicate the positions of the molecular weigiit markers in thousands. 
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Table 1. Quantitative analysis of the effects of IL-6 and TNF-a on SIP24 production by BNL 
cells. 
Treatment BNL Cell 
control 1.00 ±0.47 
IL-6 lOU/ml 0.10 ±0.01 
IL-6 lOOU/ml 1.16 ±0.51 
IL-6 1000 U/ml 1.13 ±0.28 
TNF-a 0.1 ng/ml 4.73 ± 1.37 
TNF-a 1 ng/ml 8.60 ± 0.48 
TNF-a 10 ng/ml 5.70 ± 2.09 
IL-6 100 U/ml 
TNF-a 1 ng/ml 
11.69 ±0.04 
Cells were incubated with IL-6 and/or TNF-a for 24 hours and then labeled for 4 hours. The 
relative amounts of SIP24 protein in culture media from cells treated with various concentrations 
of IL-6 and TNF-a were determined by scanning each band on the fluorograms. The obtdned 
values were normalized to the TCA precipitable cpm of matched postnuclear supematants of the 
labeled cells. Each value is the average of duplicates from a single experiment. The standard 
deviations are shown. This experiment was repeated twdce with similar results. Details are 
described in Materials and Methods. 
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DISCUSSION 
We have shown that 24P3 mRNA encodes a protein that is identical in all known aspects 
to SIP24. Thus, we propose that SIP24 and the protein encoded by the 24P3 mRNA are the 
same protein. We base our conclusion on the following structural evidence. First, the derived 
amino acid sequence of 24P3 has 200 amino acid residues with a putative signal peptide of IS 
N-terminal hydrophobic residues and its calculated Mr. is 22,800 (10), whereas SIP24 is 
secreted, has approximately 180 amino acid residues, and its estimated Mr. is 21,000 excluding 
the polysaccharide moiety (9). Second, six different peptides derived from SIP24 showed 
identity with the 24P3 sequence. This identity covers the length of the protein. Third, the 
deduced 24P3 protein sequence has a potential N-glycosylation site (10), and SIP24 is N-
glycosylated (9). Fourth, antiserum raised against SIP24 purified from 3T3 cells recognizes the 
same protein as do antisera raised ag^nst the 24P3 protein which had been expressed in and 
purified from£I coli. Fifth, probes for 24P3 mRNA and SIP24 protein detected an mRNA and 
a protein that were regulated in the same way in vivo. Based on this information, which showed 
that SIP24 and the 24P3-encoded protein are structurally and immunologically related and are 
regulated identically in vivo and in cultured cells, we conclude that the 24P3 mRNA encodes the 
SIP24 protein. Thus we refer to this protein as SIP24/24P3. 
Our results of turpentine and dexamethasone injection experiments have clearly shown that 
SIP24/24P3 is induced in the liver in a manner indicative of a positive APP. Because 
SIP24/24P3 is expressed at about the same levels in both males and females it is unlikely that sex 
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hormones play a major role in regulating its expresaon. By comparison, the related lipocalin and 
APP, rat otj-microglobulin is only synthesized in male liver (19). 
The results of our tissue distribution studies show that SIP24/24P3 is primarily expressed 
in liver during the APR. However, it is also expressed at lower levels in the brain and uterus 
during the APR. As reviewed by Aldred et al. (4), the liver is not the only site of APP 
expression, even though it is the most important one in terms of magnitude of production. For 
example, brain is an organ for which the extracellular compartment is separated by the blood-
brain barrier from the main vascular/extravascular body compartment. So, it may be desirable 
for the brain to synthedze its own APPs when needed. The levels of messenger RNAs encoding 
several APPs are altered in the brains of various species during the APR. These proteins include 
rat transferrin, transthyretin, ceruloplasmin, and retinol-binding protein (4). 
SIP24/24P3 was also found expressed in the pregnant uterus in the unstressed animal. 
Besides liver, several APPs are also expressed in the tissues comprising the interface between the 
maternal and fetal body compartment in the pregnant animal; such tissues include uterus, placenta 
and yolk sac (4). Extensive tissue remodelling takes place during pregnancy with the constantly 
changing interaction between the fetus and the tissues of the maternal reproductive tract. The 
APPs may be needed to control the extent of tissue damage during pregnancy. 
Although SIP24/24P3 mRNA was induced in mouse kidney primary cell culture after SV-40 
infection (10), we did not detect any SIP24/24P3 mRNA expressed in kidney in either saline- or 
turpentine-treated mice. There are several possible explanations for these observations: 1) 
S1P24/24P3 mRNA may be expressed in the kidney at a level below the sensitivity of our assays; 
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2) conditions in vivo are different from those to A^ch cultured cells are subjected; or 3) different 
&ctors may be required to induce SIP24/24P3 in nonparenchymal tissues such as the kidney. It 
has been reported that hepatic nonparenchymal cells produced IL-6 in response to intraperitoneal 
endotoxin (lipopolysaccharide) but not in response to intramuscular turpentine injection (20). 
The regulation of APP expression is extremely complex with many r^;ulatory humoral factors 
being involved (2,3,5,20,21). The regulation of SIP24/24P3 seems to be no exception. In Balb/c 
3T3 cells, we have previously shown that SIP24/24P3 can be induced by serum, bFGF, epidermal 
growth factor (EGF), prostaglandin F2ot, and phorbol myristate acetate (7-9). Here we have 
shown that the two major APR regulating factors, IL-6 and TNF-a, differently regulate 
SIP24/24P3 expression in BNL cells. BNL cells are a Balb/c normal liver cell line that has been 
used to study the regulation of the APP, rabbit serum amyloid A protein gene (22). The ability 
of SIP24/24P3 to be induced by TNF-a indicates that it is a type-1 APP (2). 
When the magnitudes of SIP24/24P3 induction after turpentine and dexamethasone 
injection are compared, it is clear that glucocorticoids cannot account for the entire increase in 
SIP24/24P3 during the APR. As for many other APPs, the interplay among various inducing 
factors may be necessary to achieve maximum induction of SIP24/24P3 in vivo and in cultured 
cells (2,3,5). This possibility and the underlying mechanism of SIP24/24P3 regulation are 
currently under investigation in our laboratory. 
Our current knowledge of the structure and regulation of SIP24/24P3 provide several clues 
relating to its possible function. Based upon the fact that SIP24/24P3 protein is produced both 
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upon viral infection and lipopolysacchaiide induction in cultured cells, Meheus et al. (13) have 
suggested that SIP24/24P3 could play a role in the defense mechanism against infection. Our 
identification of SIP24/24P3 as an APP suggests that it may be involved in homeostasis and have 
an anti-inflammatory role. A number of factors that induce SIP24/24P3, including bFGF, EGF, 
and dexamethasone, also been shown to have efifects on cultured cells which would be anti­
inflammatory in vivo (2,23). We have also shown that the tumor promoter 12-0-
tetradecanoylphorbol-13-acetate (PMA) induces SIP24/24P3. PMA activates PKC, which 
induces specific acute phase responses (2,24). 
The identification of SIP24/24P3 as a member of the lipocalin protein family suggests that 
SIP24/24P3 might be a binding protein for small hydrophobic molecule(s). We have reported 
that PGF2a also induces SIP24 production in 3T3 cells (7). This prostaglandin is a mitogen for 
3T3 cells (25). Many prostaglandins, including PGF2a, are released as a result of increased 
metabolism of arachidonic acid during the APR (2). Prostaglandins are also produced at different 
rates throughout pregnancy (26). So, it is possible that the level of SIP24/24P3 is regulated 
during the APR and in pregnancy in response to released PGF2a. We speculate that 
SIP24/24P3 may have an anti-inflammatory role and that this role might involve the ability of 
SIP24/24P3 to bind a PG-like molecule. 
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ABSTRACT 
Mouse SIP24/24P3 is a 24 k Da lipocalin that has been recently identified as a new acute 
phase protein (APP). During the acute phase response (APR), SIP24/24P3 mRNA is 
dramatically increased in liver and the protein is secreted into bloodstream. The identification 
of SIP24/24P3 as an APP suggests that SIP24/24P3 may be involved in the systemic 
inflammatory response. Although liver is the major site of SIP24/24P3 synthesis during the APR, 
SIP24/24P3 is also expressed in the uterus. The uterus undergoes extensive tissue remodeling 
during pregnancy and suffers stress and tissue damage around parturition. A time course study 
was carried out to investigate the variation in expression of SIP24/24P3 during pregnancy and 
around birth. Northern blot and Western blot analyses showed that SIP24/24P3 protein and 
mRNA are mas^ely expressed in the uterus around parturition. On the other hand, contrary to 
the expression pattern during the APR, liver expression of SIP24/24P3 is marginal or 
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undetectable. Despite its massive expression in the uterus, SIP24/24P3 was not detected in the 
blood or amniotic fluid. The results suggest that SIP24/24P3 is expressed locally in the uterus 
around birth and that it could be involved in the local inflammatory response associated vath 
parturition. 
INTRODUCTION 
Inflammation, initiated in the host following infection, trauma, or tissue-damaging stimuli 
involves both local and systemic changes ((Raynes, 1994; Gauldie et al., 1992; Leirisalo-Repo, 
1994; Smith, 1994). Local responses include the release of cellular contents such as histamine, 
prostaglandins, and lysosomal enzymes with neutrophil infiltration to the site of inflammation. 
Th^ are accompanied by vasodilation and pain with tissue swelling and redness. The systemic 
responses include the acute phase response (APR), fever, leukocytosis, and changes in plasma 
metal ion and glucocorticoid concentrations. 
One of the earliest events in inflammation is the infiltration of neutrophils into the 
inflamed site (Schleimer et al., 1989). Neutrophils, also called polymorphonuclear leukocytes 
(PMNs), are the most abundant circulating leukocytes (Smith, 1994; Schleimer et al., 1989). 
They are an important part of the initial host defense against all classes of infectious agents and 
are also involved in chronic inflammatory diseases (Leirisalo-Repo, 1994; Smith, 1994; Kubes, 
1993). When inflammation occurs, neutrophils are stimulated by chemotactic factors or 
chemoattractants that are generated at the site of inflammation (Leirisalo-Repo, 1994; Smith, 
1994; Kubes, 1993; Baboir, 1992; Klotz et al., 1994). N-formylated peptides generated fi'om 
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bacterial or mitochondrial proteins and attract neutrophils to the inflamed site in a concentration-
dependent manner (Schiffinann et al., 1975; Showell et al., 1976; Carp, 1982; Babior, 1992). 
The neutrophils then eliminate the invading organisms and damaged cells by phagocytosis and 
by releasing hydrolysing enzymes, lipid peroxidation products and oxygen-derived free radicals 
(Leirisalo-Repo, 1994; Smith, 1994; Kubes, 1993; Varani et al., 1994a; Varani et al., 1994b). 
SIP24 was discovered as an inducible proton secreted by quiescent Balb/c 3T3 fibroblast 
cells (Nilsen-Hamilton et al., 1982). Recently, we have shown that SIP24 is identical to mouse 
24P3 protein whose cDNA was cloned fi^om SV-40 infected primary kidney cells (Hraba-
Renevey et al., 1089; Liu et al., 1995). SIP24/24P3 is also expressed in mouse PUS. 1.8 
macrophage cells (Meheus et al., 1993) and BNL (Balb/c normal liver) cells (Liu et al., 1995). 
In vivo, SIP24/24P3 mRNA is expressed in the liver as well as in the uterus and the brain during 
the APR (Liu et al., 1995). The liver seems to be the major site of SIP24/24P3 synthesis, and 
SIP24/24P3 protein can also be detected in the bloodstream during the APR. The extrahepatic 
expression of SIP24/24P3 is also of interest. While the brain only expresses SIP24/24P3 
marginally during the APR, the utenis expresses SIP24/24P3 even under normal conditions (Liu 
and Kilsen-Hamilton., 1995). SIP24/24P3 shows 71% mRNA sequence identity with the human 
NGAL which is probably its human homolog (Bartsch et al., 1995). 
NGAL (neutrophil gelatinase associated lipocalin) is a 25 kDa lipocalin protein which was 
purified and cloned fi-om human neutrophils (Triebel et al., 1992; Kjeldsen et al., 1993; Bartsch 
et al., 1995). A minor portion of NGAL is covalently linked with neutrophil gelatinase (Triebel 
et al., 1992; Kjeldsen et al., 1993), a neutral metalloproteinase which degrades extracellular 
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matrix proteins and is believed to be involved in inflammation as well as tumor invasion and 
metastasis by (Varani et al., 1994a; Bartsch et al., 1995; Murphy et al., 1982; Wilhelm et al., 
1989; Hibbs et al., 1985; Liotta et al., 1986). More recent evidence suggests that NGAL may 
directly contribute to inflammation. Sengel0v et al. showed that NGAL is identical with the 
binding protein of the chemotactic factor, fMLP (N-formylmethionyl-leucyl-phenylalanine) (Allen 
et al., 1989; Sengelev et al., 1994). Despite the biochemical evidences, an in vivo study of 
NGALs involvement in inflammation is still lacking. 
As reviewed by Aldred et al., (1992) the reproductive system is a major site of 
extrahepatic synthesis of APPs during pregnancy. During pregnancy, the reproductive system 
undergoes extensive tissue remodelling. Local expression of the APPs might be required to 
control unnecessary tissue damage associated with the remodelling process. At the end of 
pregnancy, the sharp increase of prostaglandin F2a (PGF2a) in the uterus and amniotic fluid 
causes uterine smooth muscle contraction which subsequently triggers parturition (Poyser, 1981; 
Kelly, 1994; Strickland et al., 1982). Parturition is accompanied by inflammation (Kelly, 1994). 
The administration of anti-inflammatoiy agents which inhibit prostaglandin synthesis delays 
parturition (Chester et al., 1972). Also, the level of the pro-inflammatory mediator TNFa is 
sharply increased in uterus prior to parturition (De et al., 1992). 
The identification of SIP24/24P3 as an APP implies that it may be directly or indirectly 
involved in inflammation in vivo. We and others have reported the expression of SIP24/24P3 
in the uterus at specific stages of pr^nancy (Liu and Nilsen-Hamilton., 1995; Kasik et al., 1995). 
Here we present a more extensive investigation of SIP24/24P3 expression in the uterus and the 
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liver during pr^nancy and demonstrate that the Kghest levds of SIP24/24P3 mRNA and protein 
are achieved one day postparturition. Contrary to its expression pattern during the APR, 
SIP24/24P3 mRNA and protein were not expressed significantly in the liver. Also, despite the 
high levels of its mRNA expression and protein synthesis in the uterus, SIP24/24P3 was not 
detected in the bloodstream and amniotic fluid. Our results indicate that SIP24/24P3 can be 
synthesized locally in the uterus and may participate in the local inflammatory response which 
occurs during the birth-associated trauma. 
MATERIALS AND METHODS 
Materials 
The 5' segment of SIP24/24P3 cDNA cloned in pBluescript plasmid was a gift from Dr. 
Suzanne Hraba-Renevey (Embryologie Mol^lair et Morphogenese Institute, Geneva, 
Switzerland). The cloned rat 18 S rRNA in plasmid pDF8 was provided by Drs. Richard 
Torczynski and Harris Busch (Wadley Institutes of Molecular Biology, Dallas, TX; Fuke et al., 
1981). Zeta-Probe nylon membranes used for Northern blot were purchased from Bio-Rad 
Laboratories. Anti-SIP24 serum was previously prepared from rabbit in our laboratory (Davis 
et al., 1991). Nitrocellulose membranes were purchased from Micron Separation Inc. 
RNA analysis 
Pregnant and non-pregnant female CF-1 mice were sacrificed by cervical dislocation. 
Uteri and liver were frozen in liquid nitrogen and kept at -70°C until use. Organs were 
homogenized in 4 M guanidine isothio<yanate buffer and centrifiiged through CsCl to obtain total 
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RNA (Davis et al., 1986). For Northern analysis, 15 ng of total RNA was loaded in each lane 
and the components were separated by electrophoresis through a 0.9% agarose gel containing 
formaldehyde and then transferred to Zeta-Probe nylon membrane. The transferred membranes 
were hybridized with a ^ -labeled SIP24/24P3 5' s^ment cDNA probe (440 base pairs) and then 
with a ^^-labeled rat 18 S rRNA cDNA probe (750 base pair EcoRI/PstI fragment). The 
membranes were stripped between hybridizations with the two probes. The RNA band was 
visualized by autoradiography, and the resuh was quantitated by using a phosphorimager 
(Molecular Dynamics, Sunnyvale, CA). 
Protein analysis 
When mice were sacrificed, blood samples were taken by heart puncture, and sera were 
prepared subsequently (Liu and Nilsen-Hamilton., 1995). Amniotic fluids were taken at the same 
time and then centiiiuged for 5 minutes in a microcentrifuge at 14,000 x ^ at room temperature 
to remove cell debris. Tissue homogenates were prapared by homogenating 0.1 g of uterus or 
liver organ in 1 ml of 1 X IPB buffer (0.15 M NaCl, 0.1 % SDS, 1 % NP-40, 1 % Sodium 
deoxycholate, 10 mM NaPi, PH 7.2) for 30 seconds, then the tissue debris was removed by 
centrifugation at 14,000 x ^ at room temperature for 5 minutes. All the protein samples were 
stored at -20°C until use. Western blot analysis was carried out by resolving 5% serum or neat 
amniotic fluid samples (12.5 ul/lane) by SDS-PAGE with electrophoresis through 15% 
aciylamide gels. Equal volumes of tissue extracts were loaded. Protein concentrations of each 
tissue extract was determined by Bradford analysis and the results normalized to the 
concentration of protein in each sample. The proteins were transferred to nitrocellulose 
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membranes (Bumette, 1981) and then SIP24/24P3 detected by immunostaining using a 
horseradish peroxidase-conjugated secondary antibody (Organon Teknika Corp., West Chester, 
PA) and ECL Western blotting detection reagents (Amersham, Arlington, E.) to produce a 
luminescent stain. 
Statistical Analysis of Data 
Comparison of two sample means was analysed by Student's t test (Steel et al., 1980). 
RESULTS 
The expression of SIP24/24P3 mRNA is highly regulated during pregnancy 
During the period of pregnancy, CF-1 female mice were sacrificed each day and uterine 
total RNAs were extracted and analyzed by Northern blot. SIP24/24P3 mRNA was expressed 
in non-pregnant mouse uteri (Fig. 1 A). At early and middle stages of pregnancy, SIP24/24P3 
was expressed in the uterus at lower levels than in the non-pregnant mouse. Starting from late 
pregnancy (day 17 and 18), SIP24/24P3 expression increased steadily (Fig. IB). At the end of 
pregnancy (day 19), the level of SIP24/24P3 mRNA in the uterus was about 16-fold higher than 
in the non-pr^ant mouse (p<0.001). SIP24/24P3 mRNA was present at an even higher level 
in the postpartum uterus. On the first day after birth, the SIP24/24P3 mRNA level in the uterus 
reached a peak of about 37-fold compared to that of the non-pregnant mouse uterus (p<0.01). 
This massive increase brought the level of SIP24/24P3 mRNA to about 2.3-fold more than in 
turpentine treated liver (Liu and Nilsen-Hamilton, 1995) when both were measured on the basis 
of wet tissue wdght. After the first day postpartum, uterine expression of SIP24/24P3 was still 
Fig. 1 A. Northern blot analysis of uterus total RNA from female mice at various stages of pregnancy and around birth. Total RNAs 
were extracted from the uteri and resolved by agarose gel electrophoresis. The RNAs were transferred to nylon membranes and 
hybridized sequentially with ''P-labeled 24P3 and rat 18S rRNA cDNA probes. Northern blots show the result of hybridization 
with the 24P3 probe (upper panel) and the 18S probe (lower panel). One sample is shown for each day of gestation. Numbers on 
the top indicate the number of days of gestation. The day of the plug is designated as day 0. NP, non-pregnant. PI, P2 and P3 
represent the 1st, 2nd and 3rd day after parturition. Numbers on the right show the positions of the 18S and 28 s rRNA markers 
and the estimated molecular weight of the 24P3 mRNA. 
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Fig. IB. Quantitated results of SIP24/24P3 expression level after normalizing with the corresponding 18S rRNA level. Error bars 
are the sample standard error of the mean (N=2-7). 
SIP24/24P3 EXPRESSION IN UTERUS 
DURING PREGNANCY 
70 
60 
50 
^ 40 
^ 30 
20 
10 
0 I£L 
KJ\ 
NP 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 P1 P2 P3 
DAYS OF GESTATION 
58 
high but began to decrease. SIP24/24P3 expression was determined to be respectively about 
20- and 5-fold over the control nonpregnant uteri on the second and third day after birth 
respectively. 
The above results indicate that SIP24/24P3 is expressed in the uterus at high levels 
around birth. It also seems that uterine expression of SIP24/24P3 is a highly regulated event. 
Interestingly, the expression profile of SIP24/24P3 parallels that of prostaglandin F2a production 
in the uterus (Poyser, 1981). This observation may be related to our previous observation that 
the expression of SIP24/24P3 is regulated in 3T3 cells by prostaglandin F2a. 
SIP24/24P3 mRNA is not present at significant levels in the liver during pregnancy 
Because the liver is the major site of SIP24/24P3 synthesis during the APR (Liu and 
Nilsen-Hamilton, 1995), we also examined SIP24/24P3 expression in the liver at various stages 
of pregnancy. The expression level of SIP24/24P3 in liver was very low (Fig. 2). In fact, 
SIP24/24P3 message was undetectable in the liver at most time points examined. There was a 
marginal expression of SIP24/24P3 in midgestational liver, which agrees with our previous 
observation, but the expression level was much lower than observed in the liver from turpentine 
treated animals (Liu and Mlsen-Hamilton, 1995). 
S1P24/24P3 protin levels in the uterus and liver during pregnancy 
To determine whether the high levels of mRNA observed in the late gestational uterus 
were translated into protein, we screened these tissues using Western blot analysis (Fig. 3). 
Fig. 2. Northern blot of liver total RNA from female mice at various stages of pregnancy and around birth. The RNAs were 
extracted and analyzed as in Fig. lA.. NP, non-pregnant. PI and P2 represent the 1st and 2nd day after parturition. Numberson 
the right show the positions of the 18 S and 28 S rRNA markers and the estimated molecular weight of the 24P3 mRNA. Numbers 
on the top indicate the number of days of gestation. 
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Fig. 3. SIP24/24P3 protein in tiie uterus and liver during pregnancy and around birth. Uterine and liver lioniogenates were prepared 
and analyzed by Western blot as described in "Experimental Procedures". The samples were probed with both preimmune scrum 
(PI) and anti-SIP24 serum. DI6, DI9 represent 16, 19 days of gestation, PI, P2 represent the 1st and 2nd day after parturition. 
- and +T liver samples were prepared from saline- and turpentine-injected mouse livers (Liu and Nilsen-Hamilton, 1995). The 
protein concentrations of each extract in mg/ml were: uterus (D16, 4.9; D19,4.4; PI, 5; P2, 3.8) and liver (D9, 6.1; D19, 7.2; PI, 
7.5). The control is the concentrated SIP24-enriched medium (Liu and Nilsen-Hamilton, 1995). Numbers on the loft indicate the 
positions of the molecular markers expressed in thousands, from top to bottom: bovine serum albumin (67,000), ovalbumin (45,000), 
carbonic anhydrase (30,000), and cytochrome (18,000). 
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These results demonstrated comparable levels of SIP24/24P3 protein in the uterus in late 
gestation and post-parturition.as in the liver during the APP. 
S1P24/24P3 protein distribution in the bloodstream and amniotic fluid 
Blood and amniotic fluids were collected from the same animals as used for the liver and 
uterine samples. The resulting serum and amniotic fluids were analyzed by Western blot to 
detect the SIP24/24P3 protein. Serum and amniotic fluids are shown in Fig. 4 for the time points 
in pregnancy when SIP24/24P3 was found to be expressed in uterus or liver. At all time points 
examined, SIP24/24P3 was not detected in dther sera or amniotic fluid samples. By comparison, 
SIP24/24P3 protein could be detected in serum from turpentine injected mouse (Liu and Nilsen-
Hamihon, 1995). 
Fig. 4. Distribution of SIP24/24P3 protein in the blood and amniotic fluid during pregnancy and around birth. Serum (S) and 
amniotic fluid (AF) samples were prepared and analyzed by Western blot as described in "Experimental Procedures". The same set 
of samples were probed with both preimmune serum (PI) and anti-SlP24 serum. NP, non-pregnant. D9, D18, D19 represent 9, 
18, 19 days of gestation. PI, P2 represent the 1st and 2nd day after parturition. T is 5% serum from a mouse 24 hours after 
turpentine injection (Liu and Nilsen-Hamilton, 1995). A sample of SlP24-enriched cell culture medium was used as positive control 
(27). Numbers on the left indicate the positions of the molecular markers expressed in thousands, from lop to bottom: bovine serum 
albumin (67,000), ovalbumin (45,000), carbonic anhydrase (30,000), and cytochrome (18,000). 
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DISCUSSION 
Our results show that the expression of SIP24/24P3 during pregnancy is highly regulated. 
Starting from late pregnancy, the level of SIP24/24P3 mKNA and protein in the uterus increased 
through birth. A16-37 fold increase in SIP24/24P3 mRNA was seen around birth with the peak 
on the first day after birth. Compared to the expression in other organs (Liu and Nilsen-
Hamilton, 1995), the uterine expression of SIP24/24P3 is quite remarkable. For example, the 
peak magnitude of SIP24/24P3 mRNA expression (PI) is about twice the level of its expression 
in the liver during the APR (Liu and Mlsen-Hamilton, 1995). While a typical APR is thought to 
last 36-48 hours (Schreiber et al., 1982), the high level expression of SP24/24P3 in uterus lasts 
3-4 days. W^th the assumption that the period of induced liver synthesis of SIP24/24P3 during 
APR covers the period of the APR, the extent of uterine expression of SIP24/24P3 around birth 
is even more dramatic. 
During the APR, a systemic host inflammatory response, the APPs are synthesized in the 
liver, secreted into the bloodstream and distributed throughout the body (Raynes, 1994; 
Baumann et al., 1994). Our previous investigation suggests that SIP24/24P3 expression is 
regulated is a classic APP during the APR and therefore it may be involved in a systemic host 
inflammatory response (Liu and Nilsen-Hamikon, 1995). On the other hand, as reviewed by 
Aldred et al. (1992), many APPs can also be synthesized extrahepatically in the reproductive 
system during pregnancy when extensive tissue remodeling occurs. For example, rat 
(X2.macroglobulin is a typical APP which is almost solely produced by the liver during the APR. 
During pregnancy, while the liver still produces a measurable but small amounts of 
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otj-macroglobulin mRNA, the uterus and the placenta are the major organs producing 
ocj-macroglobulin mRNA. A large amount (70-80% of that produced by the inflamed liver) of 
otj-macroglobulin mRNA was found in the uterus and the placenta at days 12-15 of gestation 
(Panrucker and Lorscheider, 1983). Here our results indicate that, contrary to its expression 
pattern during the APR, SIP24/24P3 mRNA is not measurably expressed in the liver during most 
of pregnancy and after birth. At the same time, despite the massive expression of its mRNA and 
protein in the uterus, SIP24/24P3 protein is not present in the blood or in the amniotic fluid. 
Our results suggest SP24/24P3 might also be synthesized and retained locally during an 
inflammatory condition in which the liver is not involved. The localized expression of APP(s) 
such as SIP24/24P3 in the uterus might be beneficial to the host during the localized 
inflammation that occurs during parturition. 
The function of SIP24/24P3 during parturition is unknown. Recent studies of its human 
homolog human NGAL shows that it is a binding protein for fMLP (Allen et al., 1989; Sengelov 
et al., 1994). fMLP is produced at the site of inflammation from sources like bacterial proteins 
from invading organisms and mitochondrial proteins from damaged host cells (Schiffrnann et al., 
1975; Showell et al., 1976; Carp, 1982; Babior, 1992). It has been proposed that SIP24/24P3 
may also serve as a fMLP carrier and help to attract neutrophils to the site of inflammation 
(Kasik et al., 1995). Our results are consistent with this hypothesis. 
The APPs are generally believed to play an anti-inflammatory role in vivo (Raynes et al., 
1994; Baumann et al., 1994). The possible involvement of SIP24/24P3 in attracting neutrophils 
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implies that SIP24/24P3 may contribute to the amplification of inflammation process and 
therefore is more likely to be a pro-inflammatoiy instead of anti-inflammatory protein. However, 
it is also possible that SIP24/24P3 may be involved in subduing inflammation. For example, 
fMLP is also a chemotactic &ctor for macrophages (Synderman et al., 1980). Macrophages been 
proposed to help control and tenminate inflammation by phagocytosing aging and apoptotic cells 
including neutrophils at the inflamed site (Haslett et al., Savill et al., 1993). Alternatively, 
SIP24/24P3 might bind and sequester fMLP from n^trophils, thus suppressing the inflammatory 
response. 
In summary, we have demonstrated that the APP, SIP24/24P3 is present in large amounts 
in the uterus in late gestation and post-parturition. Increased expression of this protein may be 
part of the local inflammatory response in this tissue at parturition. Studies are underway to 
establish the role of SIP24/24P3 in parturition and during inflammation. 
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GENERAL SUMMARY 
Previous studies in our laboratory identified SIP24 protein as a highly regulated protein 
in Balb/c 3T3 cells (1-3). In this study, the analysis of sequence data previously reported (3) 
along with other data A^ch had been collected at the same time but not analyzed, revealed that 
six out of seven peptides of SIP24 were identical to the derived amino acid sequence of 24P3 
mRNA (4). Western blot analysis of control and SIP24-enriched media with both anti-SIP24 and 
anti-24P3 antibodies showed that both antibodies recognized the same sized protein with the 
same induction pattern. Combined with other evidence (same Mr and glycosylation pattern and 
parallel regulation patterns of mRNA and protein), we concluded that SIP24 and 24P3 are the 
same protein/mRNA. We renamed the protein as SIP24/24P3. 
Knowing its relationship with lipocalins (6, 7), and that its expression was regulated by 
dexamethasone in cultured cells (3), I tested the hypothesis that SIP24/24P3 is a new APP. A 
series of experiments were carried out to examine changes in levels of SIP24/24P3 mRNA and 
protein during the APR. It was found that after turpentine injection, SIP24/24P3 message is 
dramatically induced in the liver (over 400-fold). Dexamethasone injection induced a relatively 
moderate increase of SIP24/24P3 mRNA in liver (8-foId). When serum samples were examined, 
SIP24/24P3 protein was detected in sera after turpentine injection, whereas dexamethasone 
treatment did not induce a detectable amount of SIP24/24P3 protein in the serum. The induction 
pattern of SIP24/24P3 mRNA in the liver and that of its protein in blood clearly indicate that 
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SIP24/24P3 is an APP. The induction of SIP24/24P3 during the APR is rapid, presumably 
within 12 hours since the protein is detected in serum 12 hours after turpentine injection. 
The tissue distribution study was carried out to determine the site of SIP24/24P3 
synthesis in normal and turpentine-injected mice. Northern blot analysis revealed that during the 
APR, SIP24/24P3 message is expressed in the liver, uterus and perhaps the brain, but not in the 
heart, kidney, lung and muscle. The liver was found to be the major site of SIP24/24P3 synthesis 
during the APR In mock-injected mice, SIP24/24P3 expression was low in all organs examined 
except the uterus, where SIP24/24P3 was expressed at a significant level (6% of the level in the 
livers of turpentine-injected animals). 
Because the liver seems to be the major site of SIP24/24P3 synthesis during the APR, I 
examined the pattern of r^ulation of SIP24/24P3 expression in BNL (Balb/c normal liver) cells. 
Results of ^ ^S-methionine metabolic labeling experiments showed that one of the major mediators 
of the APR, TNFa, induces SIP24/24P3 protein with a peak induction of 8.6 fold. IL-6 seemed 
to have no effect on SIP24/24P3 expression alone, but had a synergistic effect on SIP24/24P3 
induction when added together with TNFa. The results indicate that SIP24/24P3 is a type-1 
APP and that TNFa might mediate hepatic SIP24/24P3 expression. 
After dscovering SIP24/24P3 expression in the uterus, I examined its uterine expression 
in midgestation. SIP24/24P3 mRNA was detected in the liver and the uterus, but not in the 
placenta and the fetus. The results suggest that, as well as the liver, the uterus is also an 
important site of SIP24/24P3 synthesis during pregnancy. 
76 
A time course study was performed to determine the variation in level of expression of 
SIP24/24P3 in the utems and liver during pregnancy. Northern blot analysis revealed that at 
early and middle stages of pregnancy, SIP24/24P3 is expressed in the uterus at a level 
comparable to or much lower than that of non-pregnant mice. Starting at late pregnancy, 
SIP24/24P3 expresaon increases in the uterus through birth. The highest level of expression of 
SIP24/24P3 was found before and after parturition Avith the peak on the first day after birth of 
37-fold increase compared with non-pregnant mice. This magnitude of SIP24/24P3 expression 
is quite massive even compared with that of liver expression during the APR. 
The time course study with liver samples showed that during pregnancy and after 
parturition, the liver did not express SIP24/24P3 mRNA at significant level compared with the 
uterus. In fact, at most time points examined, liver expression of SIP24/24P3 was undetectable. 
Meanwhile, an examination of SIP24/24P3 protein showed that despite the massive expression 
of its mRNA in the uterus, SIP24/24P3 protein is not present in circulating blood or amniotic 
fluid. Therefore, the high level expression of SIP24/24P3 around birth seems to be localized in 
the uterus. 
Despite the different patterns of its expression under various conditions, the expression 
of SIP24/24P3 seems to be associated with inflammatory responses. Our lab has previously 
reported that SIP24/24P3 can be induced in Balb/c 3T3 cells by serum, bFGF, TP A, 
dexamethasone and PGF2a (1-3). These factors have also been reported to be involved in 
regulating the expression of various other APPs (18-27). 24P3 cDNA was originally cloned 
from, and its mRNA was found to be induced in SV-40 infected primary kidney cells (4). The 
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regulation studies using BNL and Balb/c 3T3 cells indicate that SEP24/24P3 is induced by the 
mediators of APR including IL-6, TNFa and glucocorticoid (dexamethasone) (appendix A). 
SIP24/24P3 has also been identified as a major protein secreted fi-om mouse macrophage 
PUS. 1.8 cells stimulated by lipopolysaccharide (62). Lipopolysaccharide is an endotoxin and 
induces severe inflammation in vivo. NGAL, the human homolog of SIP24/24P3, is purified and 
cloned fi-om neutrophils (29-31), which directly participate in the inflammation process (45-48, 
51). ctj-microglobulin related protein is the rat homolog of SIP24/24P3 and has been found to 
be upregulated 10-fold in liver after injury (partial hepatectomy) (44). Here, the in vivo 
identification of SIP24/24P3 as an APP indicates that SIP24/24P3 may be involved in a systemic 
inflammatory response (APR) where it is synthesized in liver and secreted into bloodstream. The 
study of SIP24/24P3 expresaon and distribution during pregnancy and after parturition suggests 
that SIP24/24P3 is expressed locally in the uterus and may participate in local inflammatory 
response accompanying parturition. 
Extensive connective tissue remodelling takes place in uterus during parturition (15, 63, 
64). It is known that selective use of the inflammatory response is an important part of the 
effective mechanism of delivery (63, 64). The uterus has high concentration of smooth muscle 
cells which are embedded in a matrix of connective tissue consisting m^nly of collagen. The 
cervix is predominantly fibrous connective tissue with relatively few smooth muscle cells. 
Parturition involves effective uterine contraction as well as ripening of the cervix which softens 
and dilates to allow the passage of the fetus. The softening of the cervix is primarily due to 
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striking changes in the connective tissue. Cervical connective tissue is made up of collagen fibrils 
and elastin separated by the ground substance. Collagen is resistant to most extracellular 
proteases except to collagenase and leucocyte elastase. Measurement of collagenase activity in 
human cervix shows that the enzyme activity is highest during the active phase of labor. Such 
an increase of collagenase activity is thought to be generated from neutrophils infiltrated into the 
tissue around parturition. 
The function of SIP24/24P3 is unknown. We have previously speculated that 
SIP24/24P3 might bind a PG-like small hydrophobic ligand (5). With the identification of human 
NGAL as a fMLP binding protein (38, 39), it seems more likely that SIP24/24P3 might bind 
fMLP. As proposed by others (65), SIP24/24P3 may function by attracting neutrophils to the 
inflamed site during inflammation. In this respect, SIP24/24P3 would be a pro-inflammatory 
instead of an anti-inflammatory protein. However, the presumed ability of SIP24/24P3 to bind 
fMLP may contribute to inflammation in opposite way(s). For example, SIP24/24P3 may also 
help to bring macrophages to the site of inflammation and thus contribute to the control and 
termination of inflammation process (58, 59). Alternatively it may sequester fMLP and limit the 
movement of neutrophils to the uterus, thus acting as a break on the system. 
The exact cell type(s) of SIP24/24P3 synthesis in vivo is still unknown. Neutrophils are 
known to be involved in certain chemically-induced liver injuries (66-71). For example, 
neutrophils are massively present in rat liver after bacterial endotoxin injection. TNFa seems 
to mediate this endotoxin-induced hepatoxicity through a neutrophil-dependent mechanism (69). 
Pretreatment of rats with an antiserum to TNFa afforded protection against liver injury 6 h after 
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lipopolysaccharide exposure, but such a pretreatment did not affect hepatic accumulation of 
neutrophils. Meanwhile, depletion of neutrophils protects against liver injury fi-om endotoxin 
(70). It is completely possible that another cell type(s) is responsible for the major synthesis of 
SIP24/24P3 in vivo. It has been proposed that SIP24/24P3 is produced by neutrophils in vivo 
and the expression of SIP24/24P3 at the inflamed site is due to contaminating neutrophils 
infihrated into local tissues following inflammation (65). Our results are consistent with this 
hypothesis because SIP24/24P3 is expressed at inflamed site in vivo where neutrophils are 
presumably accumulated. 
The direction of future studies shall include investigations in vitro and in vivo. In order 
to examine whether SIP24/24P3 binds fMLP as does human NGAL, it is necessary to obtain the 
protein and characterize its binding specificity. The fiill length cDNA of SIP24/24P3 has been 
cloned by RT-PCR (Appendix B), so it is now possible to express the protein and carry out 
binding studies in vitro. On the other hand, it is necessary and possible to further investigate the 
role and involvement of SIP24/24P3 in various inflammation processes. For example, to address 
the question whether and to what extent SIP24/24P3 is produced by neutrophils under diflFerent 
inflammatory conditions, in situ hybridization can be performed to examine the cell type(s) which 
expresses SIP24/24P3 in vivo. Also, it is known that fMLP-activated neutrophils damage 
cultured hepatocytes as evaluated by the release of alanine aminotransferase into the medium 
(71). The effect of SIP24/24P3 on neutrophil activation by fMLP can be measured by pre-
incubating SIP24/24P3 with fMLP and neutrophils. The results will help us to understand what 
role(s) Sff 24/24P3 plays during inflammation. 
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APPENDIX A 
REGULATION OF SIP24/24P3 IN BALB/C 3T3 AND BNL CELLS 
BY IL-6, TNF-a AND DEXAMETHASONE 
The APPs are regulated by interleukin-l- and interleukin-6-type cytokines, 
glucocorticoids and growth factors (see "Introduction" in Section I). The effect of growth 
factors (bFGF, EGF) on SIP24/24P3 in Balb/c 3T3 cells are known (1-3). Here I studied the 
effects of IL-6 ( interleukin-6-type cytokine), TNF-a (interleukin-l-type cytokine) and 
dexamethasone on SIP24/24P3 production in Balb/c 3T3 and BNL cells. 
As described in the "Materials and Methods" of Section I, Balb/c 3T3 and BNL cells were 
grown to quiescence. IL-6, TNFa and dexamethasone were added at the final concentrations 
described for each experiment, and the cells were incubated for 24 hours. The medium was then 
removed, and the cells were rinsed twice with Tris-bufFered salts. The cells were then 
metabolically labeled for 4 hours by incubation with 100 uCi/ml Tran^'S-label in DME (with 10% 
of the normal methionine concentration), 0.2% calf serum, and the additions as present during 
the previous 24-h incubation. The samples of medium were resolved by SDS-PAGE, the gels 
were impregnated with 2,5-diphenyloxazole and exposed to film. The relative amounts of 
SIP24/24P3 produced under each test condition were quantitated by densitometric analysis of 
the resulting fluorograms. The results from densitometry have been shown to be proportional 
to the relative amount of radioactive label associated with each protein band. These resuUs were 
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normalized to the TCA-precipitable cpm in the post-nuclear supernatant of the cell population 
corresponding to the sample of conditioned medium. In this way, the rate of incorporation into 
each secreted protein was normalized to the overall rate of protein synthesis. The results are 
shown in Fig. 1. (Balb/c 3T3 cells) and Fig. 2. (BNL cells), and the quantitative analysis of the 
results is summarized in Table 1. From the results, it can be concluded that; 1) In Balb/c 3T3 
cells, SIP24/24P3 is induced by IL-6, TNF-a and dexamethasone. While IL-6 and TNFa have 
no additive or synergistic effect on SIP24/24P3 production, dexamethasone seems to have a 
synerpstic effect on SIP24/24P3 production with IL-6 and TNFa. 2) In BNL cells, IL-6 alone 
has little or no effect on SIP24/24P3 production. TNFa induces SIP24/24P3 at all three 
concentrations tested. Dexamethasone strongly induces SIP24/24P3 when treated alone and 
causes an even greater induction when treated with IL-6 and TNFa. The results confirmed the 
speculation that the interplay of diflFerent regulating factors may be necessary to achieve the 
maximum induction of SIP24/24P3. 
Fig. 1. Reguiation of SIP24/24P3 production by IL-6, TNF-a and dexamethasone in Balb/c 
3T3 cells. Quiescent 3T3 cells were incubated for 24 h with IL-6 and/or TNFa and/or 
dexamethasone and then metabolically labeled for 4 h. The culture media containing 
radiolabeled secreted proteins were resolved by SDS-PAGE and analyzed by fluorography. 
The X-ray films were exposed for 6 days at -70°C. The concentrations used of IL-6 (10-1000 
U/ml) and of TNFa (0.1-10 ng/ml) are shown for each lane, dexamethasone (DEX) was 
added at 400 ng/ml. Numbers on the left show the positions of the proteins used as 
molecular weight markers with their molecular weights expressed in thousands. 
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Fig. 2. Regulation of .SIP24/24P3 production by lL-6, TNFa and dexamethasone in BNL 
cells. The experiment was carried out and analyzed in the same way as for Fig. 1. except 
BNL cellw was used and the films were exposed for 32 days. 
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Table 1. Quantitative analysis of the effects of EL-6, TNFa and dexamethasone on 
SIP24/24P3 production in Balb/c 3T3 and BNL cells. The relative amounts of SIP24/24P3 
protein were determined by scanning each band on the fluorograms. The obtained values 
we .t/lXre normalized to the TCA precipitable cpm of matched postnuclear supematants of the 
labeled cells. Each value is the average of duplicates from a single experiment. The standard 
deviations are shown. This experiment was repeated three times with similar results. 
93 
TREATMENT 3T3 BNL 
Control 1.00 ±0.24 1.00 ±0.47 
IL-6 10 U/ml 1.00 ±0.02 0.10 ±0.01 
IL-6 100 U/ml 1.90 ±0.14 1.16±0.51 
IL-6 1000 U/ml 4.10 ±0.31 1.13 ±0.28 
TNF-a 0.1 ng/ml 1.03 ±0.35 4.73 ± 1.37 
TNF-a 1.0 ng/ml 2.49 ±0.17 8.60 ± 0.48 
TNF-a 10.0 ng/ml 4.05 ± 0.32 5.70 ±2.09 
IL-6 100 U/ml 
TNF-a 1.0 ng/ml 
2.30 ± 0.22 11.69 ±0.44 
DEX 400 ng/ml 2.25 ±0.17 14.64 + 0.36 
DEX 400 ng/ml 
IL-6 100 U/ml 
9.69 ±0.12 19.25 ±0.14 
DEX 400n^ml 
TNF-a 1.0 ng/ml 
9.28 ±0.33 19.45 ±0.33 
DEX 400 ng/ml 
IL-6 100 U/ml 
TNF-a 1.0 ng/ml 
10.79 ±0.20 23.68 ±0.14 
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APPENDIX B 
RT-PCR CLONING AND SUBCLONING OF FULL LENGTH SIP24/24P3 
RT-PCR was carried out to clone the full length S1P24/24P3 cDNA. Based on the 
published cDNA sequence (4), the forward PGR primer was designed to be identical with the 5' 
end of the sense strand and the reverse primer was designed to be complementary to the 3' end 
of the sense strand. To facilitate the subsequent cloning, Xho I and Hind m restriction enzyme 
sites were added to the ends of the two primers respectively. The RNA template was total RNA 
extracted from Balb/c 3T3 cells superinduced with dexamethasone and cycloheximide (5). The 
cDNA template was obtained by reverse transcribing 5 ug of the total RNA template, and PGR 
was carried out to amplify the cDNA template. The amplified DNA was extracted, digested with 
Xho I and Hind m. Then the cDNA was extracted again and ligated into the plasmid 
pBluescript. The plasmid construct was electroporated into XL-1 blue cells and examined. Six 
out of 10 colonies examined were found to contain the expected insert of about 0.87 kb. Three 
clones were purified and sequenced using T3, T7-2 primers and the newly synthesized QL685 
primer which corresponds to position 594-613 in published 24P3 cDNA. All three clones were 
found to be identical to 24P3 cDNA with the exception of a single point mutation in each at 
three different positions within the coding region. Two clones were digested with Xmn I 
respectively and the mutation-free regions from these two clones were ligated together to 
generate a mutation free fiill length cDNA. An alignment of the religated fiill length cDNA 
sequence with the reported 24P3 sequence is shown in Fig. 1.. 
I 
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The cloning of fiill length 24P3 cDNA makes it possible to express the protein and 
subsequently characterize its property and fiinction. 
Fig. 1. Alignment ofRT-PCR cloned fiill length cDNA with 24P3 sequence. The sequence 
on the top is the RT-PCR cloned fiill length cDNA. The sequence at the bottom is the 24P3 
cDNA. 
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